Literature DB >> 24958938

Dabigatran for mechanical valves.

Patricia A Howard1.   

Abstract

Entities:  

Year:  2014        PMID: 24958938      PMCID: PMC4062744          DOI: 10.1310/hpj4904-334

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


× No keyword cloud information.
  15 in total

1.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John J You; Daniel E Singer; Patricia A Howard; Deirdre A Lane; Mark H Eckman; Margaret C Fang; Elaine M Hylek; Sam Schulman; Alan S Go; Michael Hughes; Frederick A Spencer; Warren J Manning; Jonathan L Halperin; Gregory Y H Lip
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Dabigatran and mechanical heart valves--not as easy as we hoped.

Authors:  Elaine M Hylek
Journal:  N Engl J Med       Date:  2013-08-31       Impact factor: 91.245

4.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

5.  Fatal association of mechanical valve thrombosis with dabigatran: a report of two cases.

Authors:  Shaul Atar; Alice Wishniak; Alexander Shturman; Sewaed Shtiwi; Marc Brezins
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

6.  Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves.

Authors:  Stephen H McKellar; Stuart Abel; Christopher L Camp; Rakesh M Suri; Mark H Ereth; Hartzell V Schaff
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03-22       Impact factor: 5.209

Review 7.  Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician.

Authors:  Tiago L L Leiria; Renato D Lopes; Judson B Williams; Jason N Katz; Renato A K Kalil; John H Alexander
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

8.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

Review 9.  Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.

Authors:  S C Cannegieter; F R Rosendaal; E Briët
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

10.  Dabigatran versus warfarin after mechanical mitral valve replacement in the swine model.

Authors:  John L Schomburg; Eduardo M Medina; Matthew T Lahti; Richard W Bianco
Journal:  J Invest Surg       Date:  2012-06       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.